Author

Hui-Lan Zhu

h-index 4 View on Semantic Scholar

We have 1 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A case of neurofibromatosis type 1 caused by a novel NF1 mutation

The clinical response to the MEK inhibitor selumetinib, including regression of subcutaneous nodules, with no significant improvement in cutaneous neurofibroma scores was observed, is described.

Feng-Mei He, Xin Zhou, Hui-Lan Zhu et al. · SKINdeep · 0 citations